150 related articles for article (PubMed ID: 6159372)
1. Changes in the molecular size distribution and post-transfusion survival of hydroxyethyl starch 350/0.60 as influenced by a lower degree of hydroxyethylation: a study in normal man.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1980 Sep; 33(9):880-4. PubMed ID: 6159372
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
[TBL] [Abstract][Full Text] [Related]
3. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
Mishler JM; Ricketts CR; Parkhouse EJ
J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
[TBL] [Abstract][Full Text] [Related]
4. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
Mishler JM
Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
Mishler JM
Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
[TBL] [Abstract][Full Text] [Related]
7. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
Mishler JM; Ricketts CR; Parkhouse EJ
Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyethyl starch.
Thompson WL
Dev Biol Stand; 1980; 48():259-66. PubMed ID: 6168505
[TBL] [Abstract][Full Text] [Related]
9. Intravascular persistence of hydroxyethyl starch (HES) after serial granulocyte collections using HES in man.
Ring J; Sharkoff D; Richter W
Vox Sang; 1980 Oct; 39(4):181-5. PubMed ID: 6163255
[TBL] [Abstract][Full Text] [Related]
10. Intravascular persistence of hydroxyethyl starch in man.
Boon JC; Jesch F; Ring J; Messmer K
Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
[TBL] [Abstract][Full Text] [Related]
11. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
Mishler JM; Parry ES
Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
[TBL] [Abstract][Full Text] [Related]
12. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
Mishler JM; Dürr HK
Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethyl starch serum levels in leukapheresis donors measured by modified periodic acid-Schiff staining technique.
Trivedi SM; Humphrey RL; Braine HG; Frondoza CG
Transfusion; 1984; 24(3):260-3. PubMed ID: 6203192
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.
Lehmann G; Marx G; Förster H
Drugs R D; 2007; 8(4):229-40. PubMed ID: 17596109
[TBL] [Abstract][Full Text] [Related]
15. Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition.
Mishler JM; Ricketts CR; Parkhouse EJ; Borberg H; Gross R
J Lab Clin Med; 1979 Dec; 94(6):841-7. PubMed ID: 501207
[TBL] [Abstract][Full Text] [Related]
16. Chemical characterization of the persistent fraction of hydroxyethyl starch in rat serum and spleen.
Sum CY; Lai CM; Yacobi A; Kalhorn TF
Life Sci; 1983 Nov; 33(20):1989-94. PubMed ID: 6196590
[TBL] [Abstract][Full Text] [Related]
17. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study.
Jungheinrich C; Sauermann W; Bepperling F; Vogt NH
Drugs R D; 2004; 5(1):1-9. PubMed ID: 14725484
[TBL] [Abstract][Full Text] [Related]
18. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
[TBL] [Abstract][Full Text] [Related]
19. Macroamylasemia induced by hydroxyethyl starch--confirmation by gel filtration analysis of serum and urine.
Mishler JM; Dürr GH
Am J Clin Pathol; 1980 Oct; 74(4):387-91. PubMed ID: 6158858
[TBL] [Abstract][Full Text] [Related]
20. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
Mishler JM; Parry ES; Sutherland BA; Bushrod JR
Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
